Currently out of the existing stock ratings of Ross Muken, 75 are a BUY (72.12%), 20 are a HOLD (19.23%), 9 are a SELL (8.65%).

Ross Muken

Work Performance Price Targets & Ratings Chart

Analyst Ross Muken works at EVERCORE with a stock forecast success ratio of 87.39% fulfilled within 361.62 days on average.

Ross Muken’s has documented 202 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on A, Agilent Technologies at 16-Aug-2023.

Wall Street Analyst Ross Muken

Analyst best performing recommendations are on MDRX (ALLSCRIPTS HEALTHCARE SOLUTIONS).
The best stock recommendation documented was for MDRX (ALLSCRIPTS HEALTHCARE SOLUTIONS) at 10/12/2018. The price target of $14 was fulfilled within 4 days with a profit of $0.62 (4.63%) receiving and performance score of 11.58.

Average potential price target upside

DGX Quest Diagnostics orporated ICLR ICON PLC MCK McKesson PDCO Patterson Companies RAD Rite Aid A Agilent Technologies ABC AmerisourceBergen ATHN athenahealth CAH Cardinal Health HSIC Henry Schein WBA Walgreens Boots Alliance CERN Cerner Corp ILMN Illumina IQV IQVIA Holdings LH Laboratory of America Holdings Q Quintiles Transnational QGEN Qiagen NV TMO Thermo Fisher Scientific TWST Twist Bioscience Corp EHTH eHealth CRL Charles River Laboratories CVS CVS Health Corp DHR Danaher MDRX Allscripts Healthcare Solutions PINC Premier WAT Waters

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

155

$29.66 (23.66%)

135

16 days ago

7/8 (87.5%)

$27.58 (21.64%)

167

Hold

145

$19.66 (15.69%)

160

21 days ago

8/12 (66.67%)

$20 (16.00%)

296

Hold

145

$19.66 (15.69%)

106

1 months 20 days ago

5/6 (83.33%)

$5.32 (3.81%)

598

Buy

160

$34.66 (27.65%)

163

2 months 11 days ago

0/2 (0%)

$20.59 (14.77%)

Hold

137

$11.66 (9.30%)

150

2 months 16 days ago

6/6 (100%)

$1.78 (1.32%)

125

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ross Muken?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?